Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5326
LivePerson
LPSN
$35.2M
| $558K | ﹤0.01% |
3,232
+641
| +25% | +$120K |
|
|
NXEO
5327
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
| $557K | ﹤0.01% |
61,115
+45,108
| +282% | +$356K |
|
5328
ABM Industries
ABM
$2.82B
| $556K | ﹤0.01% |
14,753
-27,003
| -65% | -$1.12M |
|
5329
PUT
Graco
GGG
$13.3B
| $556K | ﹤0.01% |
+12,300
| New | +$532K |
|
|
VTLE
5330
PUT
DELISTED
Vital Energy
VTLE
| $556K | ﹤0.01% |
2,620
+785
| +43% | +$172K |
|
|
DERM
5331
CALL
DELISTED
Dermira, Inc.
DERM
| $556K | ﹤0.01% |
20,000
+2,000
| +11% | +$53K |
|
|
QVM
5332
DELISTED
Arrow QVM Equity Factor ETF
QVM
| $556K | ﹤0.01% |
20,052
+787
| +4% | +$21.2K |
|
|
TGH
5333
PUT
DELISTED
Textainer Group Holdings limited
TGH
| $555K | ﹤0.01% |
25,800
+14,900
| +137% | +$308K |
|
5334
Best Buy
BBY
$18.2B
| $554K | ﹤0.01% |
8,086
-90,720
| -92% | -$5.37M |
|
5335
CALL
Morningstar
MORN
$7.78B
| $553K | ﹤0.01% |
5,700
+1,800
| +46% | +$162K |
|
|
NAK
5336
Northern Dynasty Minerals
NAK
$908M
| $553K | ﹤0.01% |
312,330
+132,168
| +73% | +$262K |
|
5337
PUT
TherapeuticsMD
TXMD
$24M
| $553K | ﹤0.01% |
1,832
+984
| +116% | +$274K |
|
|
ATCO
5338
PUT
DELISTED
Atlas Corp.
ATCO
| $553K | ﹤0.01% |
81,900
+60,500
| +283% | +$395K |
|
5339
iShares MSCI Singapore ETF
EWS
$1.17B
| $552K | ﹤0.01% |
21,294
-3,691
| -15% | -$94.9K |
|
5340
CALL
Monro
MNRO
$359M
| $552K | ﹤0.01% |
9,700
+2,900
| +43% | +$151K |
|
5341
Ribbon Communications
RBBN
$377M
| $552K | ﹤0.01% |
71,413
-34,051
| -32% | -$261K |
|
|
JJC
5342
CALL
DELISTED
iPath Bloomberg Copper Subindex Total Return ETN due October 22, 2037
JJC
| $552K | ﹤0.01% |
14,700
-100
| -0.7% | -$3.54K |
|
5343
CALL
Teekay
TK
$1.09B
| $551K | ﹤0.01% |
59,100
+11,700
| +25% | +$101K |
|
5344
Vanguard Morningstar Large-Cap ETF
VV
$54.8B
| $550K | ﹤0.01% |
4,486
+2,639
| +143% | +$315K |
|
5345
CALL
Aon
AON
$75.5B
| $549K | ﹤0.01% |
4,100
-10,500
| -72% | -$1.49M |
|
5346
Kirby Corp
KEX
$7.32B
| $549K | ﹤0.01% |
8,227
+2,149
| +35% | +$141K |
|
5347
PUT
Unum
UNM
$14.8B
| $549K | ﹤0.01% |
+10,000
| New | +$537K |
|
5348
CALL
Fortune Brands Innovations
FBIN
$5.71B
| $548K | ﹤0.01% |
9,360
+3,627
| +63% | +$206K |
|
|
MRTX
5349
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $548K | ﹤0.01% |
30,048
+7,193
| +31% | +$112K |
|
|
5350
TherapeuticsMD
TXMD
$24M
| $547K | ﹤0.01% |
1,811
+1,284
| +244% | +$357K |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.